When the company, via its shareholders, is bearing the costs, including the development of the 3 proposed options for the GenViro tests kits, the patent legal counsel, etc., it seems obvious the company should "own" the final product, i.e. the patent! Unfortunately, all bets are off when one individual controls everything, makes the decisions, and negotiates with himself, while providing no details.
How do you know if any of this is true? You don't.
Market Data 
Markets 
